期刊文献+

siRNA沉默Livin基因表达对肝癌细胞HepG2生物学行为的影响 被引量:2

Influence of siRNA silencing expression of Livin gene on the biological behavior of HepG2 cells
下载PDF
导出
摘要 目的:研究应用siRNA沉默Livin基因表达后肝癌细胞HepG2的生物学功能变化。方法:用脂质体lipofectamineTM2000将携带Livin基因的siRNA载体转染至HepG2细胞内,RT-PCR、Westernblot检测转染前后Livin基因mRNA和蛋白质的表达改变;流式细胞技术(FCM)和TUNEL检测转染前后肝癌细胞凋亡变化。结果:RT-PCR及Western blot检测发现转染siRNA后Livin基因的mRNA和蛋白质表达均明显下降(P<0.05);FCM检测发现实验组、阴性对照组和空白组肝癌细胞HepG2在G1期所占比例分别是(58.99±1.173)%、(41.85±2.82)%、(41.25±1.24)%,实验组与其他两组比较差异均有统计学意义(P<0.05);TUNEL技术检测表明实验组肝癌细胞HepG2凋亡数目明显增加,细胞凋亡率为(67.56±2.56)%,凋亡率明显高于阴性对照组(27.21±12.58)%和空白组(14.09±5.16)%(P<0.05)。结论:在肝癌细胞HepG2中,Livin基因沉默具有诱导肝癌细胞凋亡、抑制肝癌细胞生长的作用。 Objective: To explore the biological significance of silencing Livin gene expression with siRNA in hepatocellular carcinoma HepG2 cells. Methods: HepG2 cells were transfected with synthetic small interfering RNA (siRNA) targeting Livin. Expression of Livin mRNA and protein wererespectively measured by reverse transcription polymerase chain reaction (RT-PCR) and Western blot. Flow cytometry (FCM) and TUNEL assay were used to examine cell cycle and apoptosis in transfected ceils. Results: The result of RT-PCR and Western blot showed that the mRNA and protein levels of Livin declined markedly in transfected cells (P〈0.05). FCM demonstrated that the cell cycle was arrested in the G1 phase, the apoptotic rate in those groups were (58.99± 1.173)%, (41.85± 2.82)%, (41.25 ± 1.24)%, as the transfected group, there were significant differences compared with other two groups (P〈0.05). The result of TUNEL assay indicated that the number of apoptotic cells in transfected group were obviously increase, the apoptotic rate was (67.56 ± 2.56) %, there were significant differences compared with negative control group (27.21 ±12.58)% and mock group (14.09 ± 5.16)%(P〈0.05). Conclusion: siRNA-mediated downregulation of Livin expression can induce apoptosis and diminish the growth, proliferation in hepatocellular carcinoma HepG2 cells.
出处 《中国现代普通外科进展》 CAS 2012年第12期935-939,共5页 Chinese Journal of Current Advances in General Surgery
基金 山东省自然科学基金项目(Y2008C110)
关键词 肝细胞 肝癌细胞 HEPG2 siRNA 基因 LIVIN Carcinoma, hepatocellular-HepG2 cellssiRNA.Gene,Livin
  • 相关文献

参考文献7

二级参考文献51

  • 1Wei Lv Chao Zhang Jia Hao.RNAi technology: A Revolutionary tool for the colorectal cancer therapeutics[J].World Journal of Gastroenterology,2006,12(29):4636-4639. 被引量:8
  • 2Zain Paroo,Qinghua Liu,Xiaodong Wang.Biochemical mechanisms of the RNA-induced silencing complex[J].Cell Research,2007,17(3):187-194. 被引量:5
  • 3陈家军,孙宗全,董念国,苏刚,刘超,刘金平,邓勇志.RNA干扰抑制MyD88表达对小鼠骨髓树突状细胞生物学活性的影响[J].细胞与分子免疫学杂志,2007,23(3):193-196. 被引量:14
  • 4Ashhab Y,Alian A,Polliack A,et al.Two splicing variants of a inhibitor of apoptosis gene with different biological properties and tissue distribution pattern[J] .FEBS Letters, 2001,495(1/2) :56 - 60.
  • 5Vucic D, Stennicke HR, Pisabaiyo MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melamoma [ J ]. Current Biology, 2000, 10( 21 ) : 1359 - 1366.
  • 6Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member[J] .J Biol Chem, 2001, 276(5): 3238 - 3264.
  • 7Song E, Lee SK,Wang J,et al. RNA interference targeting Fas protects mice from fulminant hepatitis[J] . Nat Med, 2003, 9(3) :347- 351.
  • 8Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference[J] Cancer Cell, 2002,2(3):245- 249.
  • 9Sui G, Soohoo C, Affar B, et al.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells [J] . Proc Natl Acad Sci USA,2002,99(8): 5515-5520.
  • 10Vueic D, Stennicke HR, Pisabarro MT, et al .ML-IAP, a novel inhibitor of apoptosis that is prefer-entially expressed in human melanomas [ J ]. Curr Biol, 2000, 10 (21 ) : 1359 - 1366.

共引文献63

同被引文献22

  • 1常宏,吴泰璜,穆庆岭,李乐平,潘晓华,靖昌庆.凋亡抑制蛋白Survivin的表达与肝细胞肝癌预后的关系[J].中华普通外科杂志,2004,19(12):755-757. 被引量:2
  • 2于利利,王泽华.凋亡抑制蛋白Livin shRNA真核表达载体的构建[J].华中科技大学学报(医学版),2007,36(4):489-491. 被引量:6
  • 3Sib|ey CR, Seow Y, Wood MJ. Novel RNA-based strategies for therapeutic gene silencing[J]. Molecular Therapy, 2010,18(3):466- 476.
  • 4Chang H, Schinnner AD. Livirdmelanoma inhibitor of apoptosis pro- tein as a potential therapeutic target for the treatment of malignancy [J]. Mol Cancer Ther, 2007,6( 1 ):24-30.
  • 5Crnkovie-Mertens I, Hoppe-Seyler F, Butzl K. Induction of apopto- sis in tumor cells by siRNA-mediated silencing of the livin/ML-I- AP/KIAP gene[J]. Oncogene, 2003,22(51 ):8330-8336.
  • 6K·阿帕萨尼.RNA干扰技术-从基础科学到药物开发[M].北京:科学出版社.2007:125-135.
  • 7Brummelkamp TR, Bemards R, Agami R. A system for stable ex- pression of short interfering RNAs in mammalian cells[J]. Science, 2002,296(5567):550-555.
  • 8Kenneth NS, Duckett CS. lAP proteins: regulators of cell migration and development[J]. Curr Opin Cell Biol, 2012,24(6):871-875.
  • 9Yuan B, Ran B, Wang S. siRNA directed against Livin inhibits tu- mor growth and induces apoptosis in human glioma cells[J]. J Neu- rooncol, 2012, 107 ( 1 ):81-87.
  • 10Lau R, Pratt MA. The opposing roles of cellular inhibitor of apop- tosis proteins in cancer[J]. ISRN Oncol, 2012: 928120.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部